Exposure to cigarette smoke downregulates β₂-adrenergic receptor expression and upregulates inflammation in alveolar macrophages

References

• AI Faraj A, Shaik AS, Afzal S, et al. (2014). MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles. Int J Nanomed 9:1491–503
   PubMed Web of Science ®Google Scholar
• Calveriey PMA, MacNee W, Pride NB, et al. (2003). Chronic obstructive pulmonary disease. 2nd ed. London: Arnold, 131–4
   Google Scholar
• Churg A, Wang RD, Tai H, et al. (2004). Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 170:492–8
   PubMed Web of Science ®Google Scholar
• Costa C, Rufino R, Traves SL, et al. (2008). CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 133:26–33
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Oates T, et al. (2002). Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20:556–63
   PubMed Web of Science ®Google Scholar
• Escamilla R. (2014). COPD: beyond the respiratory system. Presse Med 43:1381–6
   PubMed Web of Science ®Google Scholar
• Farmer P, Pugin J. (2000). β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway. Am J Physiol Lung Cell Mol Physiol 279:675–82
   PubMed Web of Science ®Google Scholar
• Giebelen IA, Leendertse M, Dessing MC, et al. (2008). Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulation. Am J Respir Cell Mol Biol 39:373–9
   PubMed Web of Science ®Google Scholar
• Khurana S, Ravi A, Sutula J, et al. (2014). Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med 108:1761–70
   PubMed Web of Science ®Google Scholar
• Kuroki K, Takahashi HK, Iwagaki H, et al. (2004). β2-Adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes. J Int Med Res 32:465–83
   PubMed Web of Science ®Google Scholar
• Li M, Zhong X, He Z, et al. (2012). Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB activity in human macrophages in vitro. Int Immunopharmacol 12:643–50
   PubMed Web of Science ®Google Scholar
• Pedersen F, Holz O, Lauer G, et al. (2015). Multi-analyte profiling of inflammatory mediators in COPD sputum – the effects of processing. Cytokine 71:401–4
   PubMed Web of Science ®Google Scholar
• Rahman I. (2003). Oxidative stress, chromatin remodelling and gene transcription in inflammation and chronic lung disease. J Biochem Mol Biol 36:95–109
   PubMedGoogle Scholar
• Schreck R, Rieber P, Baeuerle PA. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10:2247–58
   PubMed Web of Science ®Google Scholar
• Shinkai N, Takasuna K, Takayama S. (2003). Inhibitory effects of formoterol on lipopolysaccharide-induced premature delivery through modulation of proinflammatory cytokine production in mice. Reproduction 125:199–203
   PubMed Web of Science ®Google Scholar
• Szulakowski P, Crowther AJ, Jiménez LA, et al. (2006). The effect of smoking on obstructive pulmonary disease. Am J Respir Crit Care Med 174:41–50
   PubMed Web of Science ®Google Scholar
• Tan KS, Nackley AG, Satterfield K, et al. (2007). Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell Signal 19:251–60
   PubMed Web of Science ®Google Scholar
• Vernooy JH, Dentener MA, van Suylen RJ, et al. (2002). Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 26:152–9
   PubMed Web of Science ®Google Scholar
• Wei W, Ming X, You-yi Z, et al. (2009). Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line. Acta Pharmacol Sin 30:1522–8
   PubMed Web of Science ®Google Scholar
• Wei W, Yuan Z, Ming X, et al. (2015). Fenoterol inhibits LPS-induced AMPK activation and inflammatory cytokine production through β-arrestin-2 in THP-1 cell line. Biochem Biophys Res Commun 462:119–23
   PubMed Web of Science ®Google Scholar
• Wex E, Kollak I, Duechs MJ, et al. (2015). The long-acting β2-agonist olodaterol attenuates pulmonary inflammation. Br J Pharmacol 172:3537–47. 10.1111/bph.13143. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Xue H, Sun K, Xie W, et al. (2012). Etanercept attenuates short-term cigarette-smoke-exposure-induced pulmonary arterial remodelling in rats by suppressing the activation of TNF-a/NF-kB signal and the activities of MMP-2 and MMP-9. Pulm Pharmacol Ther 25:208–15
   PubMed Web of Science ®Google Scholar
• Yang G, Yuan Z, Ning S, et al. (2014). Effects of one month treatment with propranolol and metoprolol on the relaxant and contractile function of isolated trachea from rats exposed to cigarette smoke for four months. Inhal Toxicol 26:271–7
   PubMed Web of Science ®Google Scholar
• Yujiao Z, Yuan Z, Yang G, et al. (2014). β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling. PLoS One 9:e97788
   PubMed Web of Science ®Google Scholar
• YuTao L, Bei H, Yu ZW. (2009). Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs. Inhal Toxicol 21:641–7
   PubMed Web of Science ®Google Scholar